SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC
HCA Healthcare, Inc.
HCA
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2025, the firm owned and operated 190 hospitals and over 2,500 outpatient facillities across 19 states and a small foothold in the United Kingdom.
Last trade$501.47
Day change-$10.315 (-2.02%)
Day range$500.06 – $514.79
Volume500,796
Market cap$106.91B
OpenXNYS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$106.91B
Price / earnings
15.78×
Price / book
-13.24×
Price / sales
1.36×
EV / sales
1.99×
EV / EBITDA
9.89×
Profitability
Earnings per share
$32.44
Return on assets
10.68%
Return on equity
-83.89%
Dividend yield
0.64%
Liquidity and leverage
Debt / equity
-6.25×
Current ratio
0.82×
Quick ratio
0.74×
Cash ratio
0.05×
Cash flow
Price / cash flow
9.57×
Price / free cash flow
17.9×
Free cash flow
$5.97B
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for HCA, quarterly periods
Line item
Q3 FY2026 Sep 30, 2026
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Revenue
$19.85B
$20.23B
$19.11B
$19.51B
$19.16B
$18.61B
$18.32B
$18.29B
Cost of revenue
$0
$0
$0
$0
$0
$0
$0
$0
Gross profit
$19.85B
$20.23B
$19.11B
$19.51B
$19.16B
$18.61B
$18.32B
$18.29B
Selling, general and administrative
$8.58B
$8.29B
$8.28B
$8.36B
$8.36B
$8.14B
$8B
$7.92B
Research and development
$0
$0
$0
$0
$0
$0
$0
$0
Total operating expenses
$16.91B
$17.16B
$16.25B
$16.3B
$16.2B
$15.64B
$15.47B
$15.43B
Operating income
$2.94B
$3.07B
$2.86B
$3.22B
$2.97B
$2.97B
$2.86B
$2.86B
Interest expense
-$607M
-$599M
-$584M
-$572M
-$561M
-$568M
-$547M
-$528M
Income before taxes
$2.37B
$2.49B
$2.29B
$2.67B
$2.42B
$2.42B
$2.33B
$2.13B
Income taxes
$521M
$564M
$430M
$509M
$515M
$524M
$502M
$447M
Net income
$1.85B
$1.93B
$1.86B
$2.16B
$1.9B
$1.89B
$1.83B
$1.69B
Net income attributable to common shareholders
$1.58B
$1.7B
$1.62B
$1.88B
$1.64B
$1.65B
$1.61B
$1.44B
EBITDA
$3.9B
$4.01B
$3.79B
$4.13B
$3.85B
$3.83B
$3.72B
$3.72B
Basic earnings per share
$7.36
$7.70
$7.25
$8.29
$7.05
$6.91
$6.52
$5.71
Diluted earnings per share
$7.27
$7.62
$7.15
$8.15
$6.96
$6.83
$6.45
$5.63
Recent news
Company coverage with links to the original publishers.
HCA Healthcare, the largest non-governmental acute care hospital operator in the U.S., is featured as a stock to watch with a #3 (Hold) Zacks Rank and an A VGM Score. Nine analysts raised earnings estimates in the last 60 days, with the consensus estimate increasing to $30.05 per share. The stock has gained 8.8% over the past four weeks, demonstrating strong momentum.
Stock markets declined for the week ended November 6, with the Nasdaq, S&P 500, and Dow falling 3.4%, 2.7%, and 0.9% respectively, as investors reassessed AI valuations and infrastructure spending. A partial recovery on Friday was driven by stronger-than-expected October employment data, though concerns about potential Fed rate hikes persisted. Zacks highlighted several outperforming stocks across its various portfolios, including HCA Healthcare and Ulta Beauty from its Focus List, Accenture from its ECAP portfolio, and dividend stocks like Procter & Gamble and Automatic Data Processing.
Humana (HUM) reported Q3 2026 adjusted loss of $0.70 per share, beating estimates, with revenues surging 26.4% to $40.83B driven by Medicare membership growth and higher premiums. The company raised its 2026 adjusted EPS guidance to at least $9.50 and projects revenues of at least $160B, though rising benefit costs and deteriorating benefit ratios remain concerns.
A $1,000 investment in HCA Healthcare made in November 2016 would be worth $6,736.76 as of November 6, 2026, representing a 573.68% gain and significantly outperforming the S&P 500's 252.67% return. The largest non-governmental acute care hospital operator in the U.S. has benefited from rising patient admissions and improved operational efficiency, though analysts maintain a Neutral rating citing concerns about exchange-related coverage losses, weak elective surgery trends, and potential Medicaid payment changes in 2027.
Following Democrats' strong performance in the 2026 midterm elections, AI and data center stocks face increased regulatory risks, particularly in key states like Texas where data center moratoriums are being considered. Investors are advised to diversify toward consumer-focused ETFs, which are supported by strong consumer spending, robust holiday sales forecasts, and potential healthcare policy improvements.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
Declared upcoming dividend$0.78 per share
Declared
Oct 26, 2026
Ex-dividend
Dec 15, 2026
Pay date
Dec 29, 2026
Ex-dividend
Amount / share
Pay date
Type
Sep 16, 2026
$0.78
Sep 30, 2026
recurring
Jun 16, 2026
$0.78
Jun 30, 2026
recurring
Mar 17, 2026
$0.78
Mar 31, 2026
recurring
Dec 15, 2025
$0.72
Dec 29, 2025
recurring
Sep 16, 2025
$0.72
Sep 30, 2025
recurring
Stock splits
Historical share-structure events and their execution dates.